Comparison of 18F-sodium fluoride positron emission tomography imaging and 99mTc-pyrophosphate in cardiac amyloidosis

[11] Gallego-Delgado M(2018)Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy Eur J Nucl Med Mol Imaging 45 1945-1955

[12] Guzzo-Merello G(2011)Molecular imaging of cardiac amyloidosis Eur J Nucl Med Mol Imaging 38 470-478

[13] de Haro-Del Moral FJ(2019)(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses Curr Cardiol Rep 21 12-201

[14] Cobo-Marcos M(2013)Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis Circ Cardiovasc Imaging 6 195-417

[15] Robles C(2016)Can nuclear imaging techniques predict patient outcome and guide medical management in hereditary transthyretin cardiac amyloidosis? Cardiovasc Pathol 25 413-670

[16] Morgenstern R(2018)Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis Curr Cardiol Rep 20 33-2714

[17] Yeh R(2011)(18)F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis JACC Cardiovasc Imaging 4 659-1774

[18] Castano A(2016)Quantification of myocardial blood flow with 82Rb dynamic PET imaging J Am Coll Cardiol 68 2712-849

[19] Maurer MS(2007)[18F]-NaF PET/CT imaging in cardiac amyloidosis Eur J Nucl Med Mol Imaging 34 1765-e92

[20] Bokhari S(2016)Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis J Nucl Cardiol 23 846-749

[11] Gallego-Delgado M(2018)Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy Eur J Nucl Med Mol Imaging 45 1945-1955

[12] Guzzo-Merello G(2011)Molecular imaging of cardiac amyloidosis Eur J Nucl Med Mol Imaging 38 470-478

[13] de Haro-Del Moral FJ(2019)(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses Curr Cardiol Rep 21 12-201

[14] Cobo-Marcos M(2013)Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis Circ Cardiovasc Imaging 6 195-417

[15] Robles C(2016)Can nuclear imaging techniques predict patient outcome and guide medical management in hereditary transthyretin cardiac amyloidosis? Cardiovasc Pathol 25 413-670

[16] Morgenstern R(2018)Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis Curr Cardiol Rep 20 33-2714

[17] Yeh R(2011)(18)F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis JACC Cardiovasc Imaging 4 659-1774

[18] Castano A(2016)Quantification of myocardial blood flow with 82Rb dynamic PET imaging J Am Coll Cardiol 68 2712-849

[19] Maurer MS(2007)[18F]-NaF PET/CT imaging in cardiac amyloidosis Eur J Nucl Med Mol Imaging 34 1765-e92

[20] Bokhari S(2016)Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis J Nucl Cardiol 23 846-749